Ligand Pharmaceuticals Ef Headquarters
Looking for information about Ligand Pharmaceuticals Ef Headquarters? The links below have collected all the necessary data.
Aug 30, 2021 · Welcome to Ligand Pharmaceuticals. Ligand is a high-growth company with economic rights to some of the world's most important medicines. Ligand Second Quarter 2021 Earnings Webcast. Portfolio. Ligand’s portfolio covers a diverse array of therapeutic areas, partners and underlying technologies with many products in late stage development. ...
https://www.yellowpages.com/emeryville-ca/mip/ligand-pharmaceuticals-ef-465968533
Get reviews, hours, directions, coupons and more for Ligand Pharmaceuticals Ef at 5980 Horton St, Emeryville, CA 94608. Search for other Pharmaceutical Consultants in Emeryville on The Real Yellow Pages®.Email: mailto:[email protected]
https://craft.co/ligand-pharmaceuticals
Aug 13, 2021 · Ligand Pharmaceuticals has 115 employees at their 1 location and $186.42 M in annual revenue in FY 2020. See insights on Ligand Pharmaceuticals including office locations, competitors, revenue, financials, executives, subsidiaries and more at Craft.Employees: 115
https://www.linkedin.com/company/ligand-pharmaceuticals
Ligand Pharmaceuticals Biotechnology San Diego, CA 3,184 followers Ligand is a high-growth company with economic rights to some of the world's most important medicines.
https://www.forbes.com/companies/ligand-pharmaceuticals/
Ligand Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in developing or acquiring technologies that help pharmaceutical companies discover and develop medicines.
https://investor.ligand.com/press-releases/detail/420/ligand-to-acquire-pfenex-inc
https://investor.ligand.com/press-releases/detail/428/ligand-completes-acquisition-of-pfenex-inc
Oct 01, 2020 · Acquired company expected to increase Ligand’s royalties by 50% annually and to contribute $60 million of total revenue in 2023. SAN DIEGO-- (BUSINESS WIRE)-- Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) today announced it has completed its tender offer for all outstanding shares of Pfenex Inc. for $437.5 million in cash, plus one non ...
https://protagenic.com/about-us/management-team/
Prior to joining Agenus, he held executive management positions at Ligand Pharmaceuticals, DuPont Merck, Incyte Pharmaceuticals, Roche Palo Alto and KineMed. Dr. Stein began his career at Merck, Sharp and Dohme. He holds an MD and a PhD in Physiology & Pharmacology from Duke University.
Have you found Ligand Pharmaceuticals Ef Headquarters information?
On our site you can find many other information about headquarters of any company. Research information about other companies.
Related Pages:
|
Recently Added Pages:
|